Difference between revisions of "NextGen-O2k Exploitation"
From Bioblast
Laner Verena (talk | contribs) |
Laner Verena (talk | contribs) |
||
| Line 1: | Line 1: | ||
{{MitoFit highlights page name}} | {{MitoFit highlights page name}} | ||
{{Template:NextGen-O2k header page name logo}} | {{Template:NextGen-O2k header page name logo}} | ||
<br /> | <br /> | ||
Revision as of 14:37, 31 July 2019
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Prepare NextGen-O2k for a successful market launch including: (1) Preparation & execution of the IPR protection plan, (2) Preparation and implementation of certifications, (3) Partner engagement and (4)
Long-term business strategy for NextGen-O2k as a medical device and as a tool for algal biotechnology.
